Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168919 · ClinicalTrials.gov registry record · NA
Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03168919 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants.
The verdict
NCT03168919, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The overall goal of this study is to determine if quantitative imaging techniques can be used to detect dynamic changes of morphology and different physiologic properties of the tumor during and after completion of radiation treatment and to predict site and time of radiation.
Interventions
- DRUG Temozolomide
- DEVICE MRI
- RADIATION Fractionated Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-10-06 |
| Est. Completion | 2018-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03168919
The ClinicalTrials.gov registry entry for NCT03168919 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Temozolomide is the first listed.
NCT03168919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03168919 about?
NCT03168919 is a clinical study titled "Image-Based Quantitative Assessment of Acute Radiation-Induced Changes in Glioma". The overall goal of this study is to determine if quantitative imaging techniques can be used to detect dynamic changes of morphology and different physiologic properties of the tumor during and after completion of radiation treatment and to predict site and time of radiation.
What is the current status of trial NCT03168919?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2016-10-06. Estimated completion is 2018-06-12.
What interventions are being tested in trial NCT03168919?
The interventions under investigation include: Temozolomide (DRUG), MRI (DEVICE), Fractionated Radiation (RADIATION).
Who is sponsoring clinical trial NCT03168919?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.